hyaluronoglucosaminidase has been researched along with Shock, Cardiogenic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adgey, AA; Geddes, JS; Pantridge, JF | 1 |
| Opolski, G; Zochowski, RJ | 1 |
| Zilcher, H | 1 |
| Chazov, EI; Nikolaeva, LF; Ruda, MIa | 1 |
| Slezák, J | 1 |
2 review(s) available for hyaluronoglucosaminidase and Shock, Cardiogenic
| Article | Year |
|---|---|
Prevention of cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Creatine Kinase; Echocardiography; Electrocardiography; Extracellular Space; Heart Rate; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nifedipine; Osmotic Pressure; Oxygen Consumption; Oxygen Inhalation Therapy; Radionuclide Imaging; Shock, Cardiogenic; Verapamil | 1980 |
[The development of ischemic damage to the myocardium and a review of methods which decrease it].
Topics: Anti-Inflammatory Agents; Calcium Channel Blockers; Coronary Circulation; Glucose; Heart Arrest, Induced; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Myocardium; Oxygen Consumption; Shock, Cardiogenic; Vasodilator Agents | 1986 |
4 other study(ies) available for hyaluronoglucosaminidase and Shock, Cardiogenic
| Article | Year |
|---|---|
[Possibilities of reducing of the area of myocardial infarction].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Cardiac Glycosides; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Nitroglycerin; Shock, Cardiogenic | 1977 |
[Measures to reduce infarct size (author's transl)].
Topics: Animals; Coronary Artery Bypass; Coronary Circulation; Energy Metabolism; Hemodynamics; Humans; Hyaluronoglucosaminidase; Infusions, Parenteral; Intra-Aortic Balloon Pumping; Methylprednisolone; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitroglycerin; Oxygen Consumption; Shock, Cardiogenic; Vasoconstrictor Agents; Vasodilator Agents | 1979 |
From the NIH: Used early after attack, hyaluronidase protects heart muscle from blood-deprivation destruction.
Topics: Animals; Heart; Heart Failure; Humans; Hyaluronoglucosaminidase; Myocardial Infarction; Shock, Cardiogenic | 1979 |
[Some new aspects of the treatment of acute myocardial infarct].
Topics: Acute Disease; Angiography; Arrhythmias, Cardiac; Coronary Angiography; Electric Countershock; Fibrinolytic Agents; Glucagon; Heart Block; Humans; Hyaluronoglucosaminidase; Myocardial Contraction; Myocardial Infarction; Myocardium; Shock, Cardiogenic | 1977 |